Jason Hollar compensation by year
CARDINAL HEALTH Summary Compensation Table · all 7 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Salary | $124,317 | $700,000 | $729,247 | $1,245,534 | $1,434,153 | $1,492,329 | $1,500,000 |
| Bonus | $1,550,000 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $2,067,619 | $2,549,444 | $2,762,792 | $14,828,888 | $20,640,912 | $13,431,441 | $16,259,918 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $149,180 | $630,000 | $320,869 | $2,383,757 | $3,112,112 | $3,551,742 | $4,278,750 |
| Pension and deferred compensation | $0 | — | $0 | $0 | $0 | $0 | $0 |
| All other | $213,137 | $71,416 | $69,791 | $318,254 | $463,532 | $500,683 | $535,681 |
| Total | $4,104,253 | $3,950,860 | $3,882,699 | $18,776,433 | $25,650,709 | $18,976,195 | $22,574,349 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CARDINAL HEALTH INC DEF 14A filed September 21, 2026, accession 0001308179-26-000402, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CARDINAL HEALTH INC filed document, accession 0001308179-26-000402. Every figure is read from that document and cited to the page and table it appears in. Filed September 21, 2026.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 460,863 | $109,482,614 | — |
| RSU | 92,603 | $21,998,769 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in CARDINAL HEALTH INC's FY2026 proxy; value at the fiscal year-end close, as the company printed it.
CARDINAL HEALTH’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Jason Hollar · this page | Chief Executive Officer | $22,574,349 |
| Aaron Alt | Chief Financial Officer | $6,860,173 |
| Deborah Weitzman | Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | $6,120,157 |
| Jessica Mayer | Chief Legal and Compliance Officer | $5,534,183 |
| Stephen Mason | Chief Executive Officer, Global Medical Products and Distribution Segment | $5,293,365 |
Board service
CARDINAL HEALTH board · FY2023–FY2026How this board is paid
Company policy: CARDINAL HEALTH pays directors a $125,000 cash retainer and $210,000 in RSUs. As stated in CARDINAL HEALTH's FY2026 proxy.
The full CARDINAL HEALTH compensation record
free company briefThis page is one person within CARDINAL HEALTH's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CARDINAL HEALTH proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CARDINAL HEALTH's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CARDINAL HEALTH's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CAH
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.